Ajellomyces capsulatus (Kwon-Chung) McGinnis et Katz, teleomorph
Application
Biomedical Research and Development Material
Emerging infectious disease research
Respiratory research
Biosafety Level
3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Type Strain
no
Preceptrol®
no
Comments
Mycelial form
Antifungal properties of cycloheximide
Isolation and in vitro antifungal activity of 6,6'-dihydroxythiobinupharidine
Medium
ATCC® Medium 28: Emmons' modification of Sabouraud's agar
Growth Conditions
Temperature: 30.0°C
Name of Depositor
MA Gordon
Isolation
human bone marrow, New York
References
Salkin IF. Dermatophyte test medium: evaluation with nondermatophytic pathogens. Appl. Microbiol. 26: 134-137, 1973. PubMed: 4795526
Salkin IF, Hurd N. Quantitative evaluation of the antifungal properties of cycloheximide. Antimicrob. Agents Chemother. 1: 177-184, 1972. PubMed: 5065214
Cullen WP, et al. Isolation and in vitro antifungal activity of 6,6'- dihydroxythiobinupharidine. J. Pharm. Sci. 62: 826-827, 1973. PubMed: 4574588
